Company Overview and News

 
Gruh Finance Limited - Allotment of ESOP/ESPS

2018-09-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

 
Gruh Finance Limited - Updates

2018-09-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

 
Check out insider trades for Sept 3; IDFC Bank, LT Finance Tech Mahindra in focus

2018-09-05 moneycontrol
Trident: Trident Group Ltd. (Old Name: Madhuraj Foundation Ltd.) (promoter) bought 15,50,000 shares through market purchase on August 31, 2018
GRUH APARINDS KMBKY RAJTV 532826 GRHFY TCHQY 532755 532259 511288 TECHM 539437 IDFCBANK KOTAKBANK 500247

 
Gruh Finance Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-08-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

 
Check out insider trades for Aug 13; ITC, YES Bank, JSW Steel, Bajaj Finance in focus

2018-08-16 moneycontrol
JSW Steel: JSW Techno Projects Management Ltd. (promoter) bought 6,70,000 shares through market purchase from August 9 to August 10, 2018
GRUH YESBANK BAJFINANCE 500228 GRHFY 532648 BJJQY YYBKY JSWSTEEL 511288 500034

 
Gruh Finance Limited - Allotment of ESOP/ESPS

2018-08-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

1
Ideas for Profit: HDFC continues steady performance in Q1, buy

2018-07-31 moneycontrol
Housing Development Finance Corporation (HDFC), the largest housing finance company, reported net profit growth of 54 percent at Rs 2,190 crore in Q1 FY19 on a low base and aided by strong loan book growth. The latter remains strong and margins stable though transition to Ind-AS led to restatement of certain line items.
GRUH HDB 500180 GRHFY HDFCBANK HDFC 500010 HDFC 511288

 
Gruh Finance Limited - Investor Presentation

2018-07-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

 
Gruh Finance Limited - Press Release (Revised)

2018-07-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

 
Gruh Finance Limited - Press Release

2018-07-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

 
Gruh Finance Limited - Financial Result Updates

2018-07-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GRUH GRHFY 511288

 
BHEL, Canara Bank, L&T, JSW Steel results

2018-07-24 thehindubusinessline
Over 50 firms will declare their April-June quarter results on Wednesday. Among these are Ambuja Cements, BHEL, Bharat Bijlee, Bharati Infratel, Canara Bank, Chemfab Alkalies, CG Consumer, Dishman Carbogen, Gruh Finance, HCL Infosys, Hero MotoCorp, India Grid, Ind-Swift, IRB infra, JSW Steel, Jubilant Food, Jyothy Labs, Karur Vysya Bank, L&T, Omaxe, PVR, RECL, Sanofi India, Shriram City Union, SKF India, Tata Elxsi, TTK Prestiege, United Bank and Welspun Enterprises.
SANOFI 500408 500425 590003 UDBKL 500228 UBLS AMBUJACEM 511288 WELENT 532483 AMBUY UBLA SKFINDIA 500674 HEROMOTOCO 503960 500472 GRUH GRHFY JSWSTEEL CNRYY 500182 532553 BBL TATAELXSI HRTQY KARURVYSYA CANBK

1
HDFC grp m-cap crosses Rs 10 tn

2018-07-11 freepressjournal.in
Mumbai : Deepak Parekh-led financial services conglomerate HDFC group saw the market capitalisation of its listed firms cross Rs 10 lakh crore mark, making it only the second Indian business house after Tatas to achieve this feat.
GRUH HDB 500180 GRHFY HDFCBANK 511288

1
HDFC group m-cap crosses Rs 10 trillion, only second after Tatas

2018-07-10 moneycontrol
Deepak Parekh-led financial services conglomerate HDFC group today saw the market capitalisation of its listed firms cross Rs 10 lakh crore mark, making it only the second Indian business house after Tatas to achieve this feat. HDFC group currently has four listed entities -- housing finance major HDFC Ltd, banking behemoth HDFC Bank, life insurance firm HDFC Standard Life and Gruh Finance -- while Tatas have nearly 30 firms listed on the stock exchange.
GRUH 532540 HDB 500180 GRHFY HDFCBANK TCS TTNQY 511288

1
HDFC Group’s market cap crosses ₹ 10 trillion, Tata Group at ₹ 11 trillion

2018-07-10 livemint
New Delhi: Deepak Parekh-led financial services conglomerate HDFC Group on Tuesday saw the market capitalisation of its listed firms cross the ₹ 10 trillion mark, making it only the second Indian business house after the Tata group to achieve this feat. HDFC Group has four listed companies—Housing Finance Development Corp. Ltd, HDFC Bank Ltd, life insurance firm HDFC Standard Life Ltd and Gruh Finance Ltd.
GRUH HDFCNIFETF 532540 HDB 500180 GRHFY HDFCBANK TCS TTNQY 539516 511288

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...